FDA Approves SetPoint Medical`s Therapy for Rheumatoid Arthritis
31 Jul 2025 //
BUSINESSWIRE
SetPoint Medical Wins Research Award at EULAR 2025 Congress
11 Jun 2025 //
BUSINESSWIRE
SetPoint Medical Appoints Tyler Binney to Its Board of Directors
04 Jun 2025 //
BUSINESSWIRE
SetPoint Receives Breakthrough Designation for Neuroimmune Modulation Platform
13 Mar 2024 //
BUSINESSWIRE
SetPoint Medical Appoints Rohan Seth as Chief Financial Officer
12 Jun 2023 //
BUSINESSWIRE
SetPoint Medical Announces Expanded $65M Credit Facility
19 Jan 2023 //
BUSINESSWIRE
SetPoint Medical Announces $80M Stock Financing for Autoimmune Diseases
19 Jan 2023 //
BUSINESSWIRE